Greg Zante
Known title: Chief Financial OfficerCIK: 0001264949
Associated companies
Transaction History
| VKTX | ▼ Sell | Open Market | 21,217 | $710K | 7/29/2026 | View on chart |
| VKTX | ▲ Buy | Grant | 31,667 | $0 | 7/28/2026 | View on chart |
| VKTX | ▼ Sell | Open Market | 31,961 | $1.0M | 1/5/2026 | View on chart |
| VKTX | ▼ Sell | Open Market | 13,900 | $464K | 1/5/2026 | View on chart |
| VKTX | ▼ Sell | Open Market | 10,300 | $353K | 1/5/2026 | View on chart |
| VKTX | ▼ Sell | Open Market | 1,500 | $48K | 1/5/2026 | View on chart |
| VKTX | ▲ Buy | Grant | 41,000 | $0 | 1/2/2026 | View on chart |
| VKTX | ▲ Buy | Grant | 32,049 | $0 | 1/2/2026 | View on chart |
| VKTX | ▼ Sell | Open Market | 6,185 | $216K | 10/28/2025 | View on chart |
| VKTX | ▲ Buy | Grant | 11,117 | $0 | 10/27/2025 | View on chart |
| VKTX | ▼ Sell | Open Market | 4,266 | $118K | 7/3/2025 | View on chart |
| VKTX | ▲ Buy | Grant | 7,667 | $0 | 7/2/2025 | View on chart |
| VKTX | ▼ Sell | Open Market | 45,609 | $1.9M | 1/6/2025 | View on chart |
| VKTX | ▼ Sell | Open Market | 4,700 | $204K | 1/6/2025 | View on chart |
| VKTX | ▲ Buy | Grant | 44,533 | $0 | 1/3/2025 | View on chart |
| VKTX | ▲ Buy | Grant | 21,667 | $0 | 1/3/2025 | View on chart |
| VKTX | ▼ Sell | Open Market | 7,967 | $643K | 10/28/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 1,206 | $98K | 10/28/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 49,672 | $3.7M | 10/28/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 18,620 | $1.4M | 10/28/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 9,265 | $713K | 10/28/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 23,082 | $1.8M | 10/28/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 15,825 | $1.2M | 10/28/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 6,050 | $483K | 10/28/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 12,750 | $99K | 10/28/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 4,251 | $20K | 10/28/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 26,000 | $151K | 10/28/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 51,000 | $435K | 10/28/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 500 | $29K | 7/30/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 2,974 | $172K | 7/30/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 12,662 | $721K | 7/30/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 21,667 | $0 | 7/29/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 6,667 | $0 | 7/29/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 30,000 | $146K | 5/3/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 17,238 | $1.3M | 5/3/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 847 | $64K | 5/3/2024 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 4,249 | $20K | 5/3/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 3,101 | $228K | 5/3/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 45,570 | $3.4M | 5/3/2024 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 16,610 | $1.4M | 3/27/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 31,667 | $0 | 3/27/2024 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 20,093 | $1.7M | 3/1/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 31,667 | $0 | 3/1/2024 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 13,872 | $258K | 1/4/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 15,000 | $269K | 1/4/2024 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 18,233 | $317K | 1/3/2024 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 30,889 | $537K | 1/3/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 70,000 | $0 | 1/3/2024 | View on chart |
| VKTX | ▲ Buy | Grant | 28,334 | $0 | 1/3/2024 | View on chart |
| VKTX | ▼ Sell | Open Market | 7,500 | $150K | 4/17/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 7,500 | $98K | 4/17/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 37,447 | $217K | 4/12/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 41,544 | $748K | 4/12/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 4,097 | $32K | 4/12/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 3,242 | $25K | 4/11/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 14,553 | $84K | 4/11/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 56,295 | $1.0M | 4/11/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 8,500 | $40K | 4/11/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 30,000 | $146K | 4/11/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 30,911 | $240K | 4/3/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 30,911 | $556K | 4/3/2023 | View on chart |
| VKTX | ▲ Buy | Grant | 56,667 | $0 | 4/3/2023 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 55,166 | $969K | 4/3/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 32,000 | $273K | 3/30/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 42,000 | $323K | 3/30/2023 | View on chart |
| VKTX | ▼ Sell | Open Market | 131,029 | $2.2M | 3/30/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 7,500 | $31K | 3/30/2023 | View on chart |
| VKTX | ▲ Buy | Option Exercise | 12,250 | $57K | 3/30/2023 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 20,708 | $174K | 1/4/2023 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 23,933 | $204K | 1/3/2023 | View on chart |
| VKTX | ▲ Buy | Grant | 90,667 | $0 | 1/3/2023 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 19,697 | $185K | 12/30/2022 | View on chart |
| VKTX | ▲ Buy | Grant | 20,233 | $0 | 12/30/2022 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 8,835 | $41K | 1/4/2022 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 3,097 | $15K | 1/3/2022 | View on chart |
| VKTX | ▲ Buy | Grant | 53,333 | $0 | 1/3/2022 | View on chart |
| VKTX | ▼ Sell | Tax Withholding | 2,306 | $15K | 9/28/2021 | View on chart |
| VKTX | ▲ Buy | Grant | 6,667 | $0 | 9/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Viking Therapeutics Launches New Oral Obesity Study
Viking Therapeutics announced a new oral maintenance study for its obesity program, a key step in its drug development pipeline. This news comes as the stock has fallen over 30% in the last three months, trading near its 52-week low. While an analyst recently maintained a buy rating with a lowered price target, the broader market view remains mixed given the recent price decline.
Viking Therapeutics Launches New Oral Obesity Study. Viking Therapeutics announced a new oral maintenance study for its obesity program, a key step in its drug development pipeline. This news comes as the stock has fallen over 30% in the last three months, trading near its 52-week low. While an analyst recently maintained a buy rating with a lowered price target, the broader market view remains mixed given the recent price decline.